Epigenetic modulators, modifiers and mediators in cancer aetiology and progression

[1]  V. Bohr.  Faculty Opinions recommendation of Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. , 2017 .

[2]  Y. Shukla,et al.  Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer. , 2016, Biochemical and biophysical research communications.

[3]  A. Vincent-Salomon,et al.  Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis , 2015, Genes & development.

[4]  M. Hirst,et al.  Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells , 2015, Nature.

[5]  A. Singh,et al.  p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling , 2015, Cancer letters.

[6]  Y. Haupt,et al.  Faculty Opinions recommendation of Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. , 2015 .

[7]  Jonghwan Kim,et al.  Tgif1 Counterbalances the Activity of Core Pluripotency Factors in Mouse Embryonic Stem Cells. , 2015, Cell reports.

[8]  T. Stricker,et al.  Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ , 2015, BMC Cancer.

[9]  E. Fredlund,et al.  PARP1- and CTCF-Mediated Interactions between Active and Repressed Chromatin at the Lamina Promote Oscillating Transcription. , 2015, Molecular cell.

[10]  A. Brunet,et al.  Epigenetic regulation of ageing: linking environmental inputs to genomic stability , 2015, Nature Reviews Molecular Cell Biology.

[11]  I. Sandovici,et al.  Differential genomic imprinting regulates paracrine and autocrine roles of IGF2 in mouse adult neurogenesis , 2015, Nature Communications.

[12]  B. Vollmer,et al.  The lysine demethylase LSD1 is required for nuclear envelope formation at the end of mitosis , 2015, Journal of Cell Science.

[13]  D. Patel,et al.  DNA methylation pathways and their crosstalk with histone methylation , 2015, Nature Reviews Molecular Cell Biology.

[14]  A. Valencia,et al.  Non-coding recurrent mutations in chronic lymphocytic leukaemia , 2015, Nature.

[15]  W. Bickmore,et al.  Chromatin at the nuclear periphery and the regulation of genome functions , 2015, Histochemistry and Cell Biology.

[16]  L. Wessels,et al.  Chemical profiling of the genome with anti-cancer drugs defines target specificities. , 2015, Nature chemical biology.

[17]  A. Børresen-Dale,et al.  Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells , 2015, Genes & development.

[18]  Lanjuan Li,et al.  Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells , 2015, Nature Communications.

[19]  D. Coppola,et al.  YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self‐Renewal and Vascular Mimicry of Stem‐Like Cells , 2015, Stem cells.

[20]  Yali Dou,et al.  Hijacked in cancer: the KMT2 (MLL) family of methyltransferases , 2015, Nature Reviews Cancer.

[21]  A. Visel,et al.  Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions , 2015, Cell.

[22]  Monther Abu-Remaileh,et al.  Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer. , 2015, Cancer research.

[23]  Yusuke Nakamura,et al.  The NSD family of protein methyltransferases in human cancer. , 2015, Epigenomics.

[24]  A. Feinberg,et al.  Age and sun exposure-related widespread genomic blocks of hypomethylation in nonmalignant skin , 2015, Genome Biology.

[25]  Tara L. Deans,et al.  A noisy tug of war: the battle between transcript production and degradation in the liver. , 2015, Developmental cell.

[26]  S. Itzkovitz,et al.  Bursty gene expression in the intact mammalian liver. , 2015, Molecular cell.

[27]  Peter Sollich,et al.  Increased signaling entropy in cancer requires the scale-free property of protein interaction networks , 2015, Scientific Reports.

[28]  Charles Y. Lin,et al.  Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. , 2015, Molecular cell.

[29]  John T. Chang,et al.  A gp130–Src–YAP module links inflammation to epithelial regeneration , 2015, Nature.

[30]  She Chen,et al.  Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability , 2015, Genes & development.

[31]  D. Zheng,et al.  Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice , 2015, Nature.

[32]  Andrew E. Teschendorff,et al.  An Integrative Multi-scale Analysis of the Dynamic DNA Methylation Landscape in Aging , 2015, PLoS genetics.

[33]  O. Bernard,et al.  TET proteins and the control of cytosine demethylation in cancer , 2015, Genome Medicine.

[34]  Wei Li,et al.  Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. , 2015, Blood.

[35]  A. Regev,et al.  Pluripotency Transcription Factor Oct4 Mediates Stepwise Nucleosome Demethylation and Depletion , 2015, Molecular and Cellular Biology.

[36]  S. Wheelan,et al.  Directed targeting of chromatin to the nuclear lamina is mediated by chromatin state and A-type lamins , 2015, The Journal of cell biology.

[37]  Héctor Corrada Bravo,et al.  Gene Expression Signatures Based on Variability can Robustly Predict Tumor Progression and Prognosis , 2015, Cancer informatics.

[38]  C. Brenner,et al.  Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation. , 2014, Cell reports.

[39]  David L. A. Wood,et al.  Divergent reprogramming routes lead to alternative stem-cell states , 2014, Nature.

[40]  Christopher A. Miller,et al.  Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. , 2014, Blood.

[41]  Robert S. Illingworth,et al.  Chromatin decondensation is sufficient to alter nuclear organization in embryonic stem cells , 2014, Science.

[42]  T. Misteli,et al.  Common features of chromatin in aging and cancer: cause or coincidence? , 2014, Trends in cell biology.

[43]  V. Corces,et al.  Architectural proteins: regulators of 3D genome organization in cell fate. , 2014, Trends in cell biology.

[44]  Aviv Regev,et al.  Deconstructing transcriptional heterogeneity in pluripotent stem cells , 2014, Nature.

[45]  H. Zhang,et al.  Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients , 2014, Oncotarget.

[46]  L. Marucci,et al.  β-catenin fluctuates in mouse ESCs and is essential for Nanog-mediated reprogramming of somatic cells to pluripotency. , 2014, Cell reports.

[47]  Wei Li,et al.  Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. , 2014, Cell stem cell.

[48]  M. Araúzo-Bravo,et al.  Nanog induces hyperplasia without initiating tumors. , 2014, Stem cell research.

[49]  Winston Timp,et al.  Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors , 2014, Genome Medicine.

[50]  J. Boros,et al.  Polycomb Repressive Complex 2 and H3K27me3 Cooperate with H3K9 Methylation To Maintain Heterochromatin Protein 1α at Chromatin , 2014, Molecular and Cellular Biology.

[51]  Michael B. Elowitz,et al.  Dynamic Heterogeneity and DNA Methylation in Embryonic Stem Cells , 2014, Molecular cell.

[52]  David T. W. Jones,et al.  Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing , 2014, Nature.

[53]  E. Appella,et al.  The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis , 2014, Oncogene.

[54]  B. Göttgens,et al.  Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. , 2014, Cell stem cell.

[55]  Anne-Kathrin Classen,et al.  Sensing cellular states—signaling to chromatin pathways targeting Polycomb and Trithorax group function , 2014, Cell and Tissue Research.

[56]  Heather L. Mulder,et al.  The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes , 2014, Nature Communications.

[57]  Ker-Chau Li,et al.  Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling , 2014, Nature Communications.

[58]  S. Armstrong,et al.  Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia , 2014, Nature Communications.

[59]  Michael R. Green,et al.  A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype , 2014, eLife.

[60]  M. Kaminski,et al.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. , 2014, Blood.

[61]  D. Friedmann-Morvinski,et al.  Dedifferentiation and reprogramming: origins of cancer stem cells , 2014, EMBO reports.

[62]  Hermann Brenner,et al.  Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. , 2014, Human molecular genetics.

[63]  Gary D Bader,et al.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy , 2014, Nature.

[64]  S. Yamanaka,et al.  Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation , 2014, Cell.

[65]  P. A. Futreal,et al.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.

[66]  G. Brodeur,et al.  Role of CHD5 in human cancers: 10 years later. , 2014, Cancer research.

[67]  M. Toyota,et al.  Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators. , 2014, Gastroenterology.

[68]  A. Feinberg,et al.  Large-scale hypomethylated blocks associated with Epstein-Barr virus–induced B-cell immortalization , 2014, Genome research.

[69]  F. Radvanyi,et al.  PRC2-independent chromatin compaction and transcriptional repression in cancer , 2014, Oncogene.

[70]  R. Grossman,et al.  Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. , 2014, Cell reports.

[71]  M. Stratton,et al.  Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.

[72]  M. Stratton,et al.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone , 2013, Nature Genetics.

[73]  S. Severini,et al.  Cellular network entropy as the energy potential in Waddington's differentiation landscape , 2013, Scientific Reports.

[74]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[75]  Michael R. Green,et al.  Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors , 2013, Genes & development.

[76]  C. Plass,et al.  Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer , 2013, Nature Reviews Genetics.

[77]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[78]  Jacob D. Jaffe,et al.  Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia , 2013, Nature Genetics.

[79]  Kajia Cao,et al.  Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape , 2013, Genes & development.

[80]  P. A. Pérez-Mancera,et al.  Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence , 2013, Genes & development.

[81]  Andrew E. Teschendorff,et al.  Age-associated epigenetic drift: implications, and a case of epigenetic thrift? , 2013, Human molecular genetics.

[82]  Xi C. He,et al.  Maternal imprinting at the H19–Igf2 locus maintains adult haematopoietic stem cell quiescence , 2013, Nature.

[83]  Guoji Guo,et al.  A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo. , 2013, Genes & development.

[84]  Andrew P. Feinberg,et al.  Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host , 2013, Nature Reviews Cancer.

[85]  S. Bohlander,et al.  Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. , 2013, Blood.

[86]  D. Miranda-Saavedra,et al.  Genomic and computational approaches to dissect the mechanisms of STAT3’s universal and cell type-specific functions , 2013, JAK-STAT.

[87]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[88]  O. Elemento,et al.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. , 2013, Cancer cell.

[89]  C. Sander,et al.  Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network , 2013, Clinical Cancer Research.

[90]  G. Ruvkun,et al.  DAF-16/FOXO employs the chromatin remodeller SWI/SNF to promote stress resistance and longevity , 2013, Nature Cell Biology.

[91]  A. Kohlmann,et al.  The molecular profile of adult T‐cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T‐ALL , 2013, Genes, chromosomes & cancer.

[92]  Jan Paul Medema,et al.  Cancer stem cells: The challenges ahead , 2013, Nature Cell Biology.

[93]  J. Lawrence,et al.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery. , 2013, Seminars in cancer biology.

[94]  A. Feinberg,et al.  Higher order chromatin organization in cancer. , 2013, Seminars in cancer biology.

[95]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[96]  B. Bernstein,et al.  Epigenetic Reprogramming in Cancer , 2013, Science.

[97]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[98]  W. Bickmore,et al.  Single-Cell Dynamics of Genome-Nuclear Lamina Interactions , 2013, Cell.

[99]  Peter W. Laird,et al.  Interplay between the Cancer Genome and Epigenome , 2013, Cell.

[100]  Yang Shi,et al.  Emerging roles for chromatin as a signal integration and storage platform , 2013, Nature Reviews Molecular Cell Biology.

[101]  E. Solary,et al.  Clonal architecture of chronic myelomonocytic leukemias. , 2013, Blood.

[102]  Kerry Bloom,et al.  Pericentric chromatin loops function as a nonlinear spring in mitotic force balance , 2013, The Journal of cell biology.

[103]  David T. W. Jones,et al.  Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas , 2013, Acta Neuropathologica.

[104]  K. Yao,et al.  Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma , 2013, PloS one.

[105]  D. Eccles,et al.  Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas , 2013, Nature Genetics.

[106]  Manolis Kellis,et al.  Constitutive nuclear lamina–genome interactions are highly conserved and associated with A/T-rich sequence , 2013, Genome research.

[107]  Rachel Patton McCord,et al.  Correlated alterations in genome organization, histone methylation, and DNA–lamin A/C interactions in Hutchinson-Gilford progeria syndrome , 2013, Genome research.

[108]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[109]  H. Clevers,et al.  Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.

[110]  R. Taneja,et al.  G9a, a multipotent regulator of gene expression , 2013, Epigenetics.

[111]  C. Stewart,et al.  The nuclear lamins: flexibility in function , 2012, Nature Reviews Molecular Cell Biology.

[112]  Eric A Bushong,et al.  Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice , 2012, Science.

[113]  Patrick J. Paddison,et al.  G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. , 2012, Genes & development.

[114]  Dereje D. Jima,et al.  The genetic landscape of mutations in Burkitt lymphoma , 2012, Nature Genetics.

[115]  Nancy F. Hansen,et al.  Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes , 2012, Nature Genetics.

[116]  W. Wong,et al.  Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming , 2012, Cell.

[117]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[118]  Zohar Mukamel,et al.  Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues , 2012, Nature Genetics.

[119]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[120]  K. Cibulskis,et al.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer , 2012, Nature Genetics.

[121]  Robert Gentleman,et al.  Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.

[122]  Angela N. Brooks,et al.  Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.

[123]  Xiaochu Yan,et al.  Nanog regulates self‐renewal of cancer stem cells through the insulin‐like growth factor pathway in human hepatocellular carcinoma , 2012, Hepatology.

[124]  Dimos Gaidatzis,et al.  Step-Wise Methylation of Histone H3K9 Positions Heterochromatin at the Nuclear Periphery , 2012, Cell.

[125]  Kristian Cibulskis,et al.  A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. , 2012, The Journal of clinical investigation.

[126]  A. Sivachenko,et al.  A Landscape of Driver Mutations in Melanoma , 2012, Cell.

[127]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[128]  Matthew J. Davis,et al.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.

[129]  Jill P. Mesirov,et al.  MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.

[130]  P. Laird,et al.  Environmental epigenetics: prospects for studying epigenetic mediation of exposure–response relationships , 2012, Human Genetics.

[131]  Elaine R. Mardis,et al.  Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.

[132]  Hui Yang,et al.  Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. , 2012, Genes & development.

[133]  Veronika Rockova,et al.  Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. , 2012, Blood.

[134]  Alfonso Valencia,et al.  Distinct DNA methylomes of newborns and centenarians , 2012, Proceedings of the National Academy of Sciences.

[135]  S. Levison,et al.  IGF‐II Promotes Stemness of Neural Restricted Precursors , 2012, Stem cells.

[136]  Andrew E. Teschendorff,et al.  Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions , 2012, Bioinform..

[137]  M. Stern,et al.  Genetic variation in insulin pathway genes and distal colorectal adenoma risk , 2012, International Journal of Colorectal Disease.

[138]  Keith A. Boroevich,et al.  Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.

[139]  A. Børresen-Dale,et al.  The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.

[140]  Adam J. Koch,et al.  The Nuclear Envelope Protein Emerin Binds Directly to Histone Deacetylase 3 (HDAC3) and Activates HDAC3 Activity* , 2012, The Journal of Biological Chemistry.

[141]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2012, Nature.

[142]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[143]  G. Boucher,et al.  A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. , 2012, Genes & development.

[144]  H. Kitchener,et al.  Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation , 2012, Genome Medicine.

[145]  A. Feinberg,et al.  Regulated Noise in the Epigenetic Landscape of Development and Disease , 2012, Cell.

[146]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[147]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[148]  David A. Orlando,et al.  Enhancer decommissioning by LSD1 during embryonic stem cell differentiation , 2012, Nature.

[149]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[150]  Raymond K. Auerbach,et al.  Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation , 2012, Cell.

[151]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[152]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[153]  Christian Bastard,et al.  TET2 and DNMT3A mutations in human T-cell lymphoma. , 2012, The New England journal of medicine.

[154]  C. Stewart,et al.  Histone modifications and lamin A regulate chromatin protein dynamics in early embryonic stem cell differentiation , 2012, Nature Communications.

[155]  Jeannie T. Lee,et al.  X-chromosome hyperactivation in mammals via nonlinear relationships between chromatin states and transcription , 2011, Nature Structural &Molecular Biology.

[156]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[157]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[158]  P. Laird,et al.  Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.

[159]  B. Ko,et al.  TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. , 2011, Blood.

[160]  J. Mason,et al.  Maternal one-carbon nutrient intake and cancer risk in offspring. , 2011, Nutrition reviews.

[161]  J. Ellenberg,et al.  Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells , 2011, Cell.

[162]  Michael A Choti,et al.  Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma , 2011, Nature Genetics.

[163]  Huanming Yang,et al.  Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.

[164]  K. Akashi,et al.  Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. , 2011, Cancer cell.

[165]  Wouter de Laat,et al.  Variegated gene expression caused by cell-specific long-range DNA interactions , 2011, Nature Cell Biology.

[166]  Steven J. M. Jones,et al.  Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.

[167]  Raul Rabadan,et al.  Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.

[168]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[169]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[170]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[171]  A. Feinberg,et al.  Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.

[172]  J. C. Belmonte,et al.  LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells , 2011, Nature Cell Biology.

[173]  R. Evans,et al.  Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis , 2011, Cell.

[174]  A. Feinberg,et al.  Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition , 2011, Nature Structural &Molecular Biology.

[175]  Yong-mei Zhu,et al.  Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.

[176]  J. Licht,et al.  DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.

[177]  Kenneth H. Buetow,et al.  CREBBP mutations in relapsed acute lymphoblastic leukaemia , 2011, Nature.

[178]  Michael A. Choti,et al.  DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.

[179]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[180]  L. Staudt,et al.  The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. , 2011, Blood.

[181]  Raul Rabadan,et al.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma , 2010, Nature.

[182]  S. Chiou,et al.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. , 2010, Cancer research.

[183]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[184]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[185]  Richard A. Moore,et al.  ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.

[186]  Tian-Li Wang,et al.  Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma , 2010, Science.

[187]  W. Johnson,et al.  DNA Demethylase Activity Maintains Intestinal Cells in an Undifferentiated State Following Loss of APC , 2010, Cell.

[188]  David Carling,et al.  Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation , 2010, Science.

[189]  H. Drexler,et al.  Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.

[190]  R. Kuiper,et al.  Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes , 2010, Nature Genetics.

[191]  Wendy A Bickmore,et al.  Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. , 2010, Molecular cell.

[192]  J. Rossant,et al.  Global Chromatin Architecture Reflects Pluripotency and Lineage Commitment in the Early Mouse Embryo , 2010, PloS one.

[193]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[194]  Rob Pieters,et al.  PHF6 mutations in T-cell acute lymphoblastic leukemia , 2010, Nature Genetics.

[195]  A. Feinberg,et al.  Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease , 2010, Proceedings of the National Academy of Sciences.

[196]  Rakhee Banerjee,et al.  Polycomb Repressive Complex 2 and Trithorax modulate Drosophila longevity and stress resistance , 2009, Proceedings of the National Academy of Sciences.

[197]  J. Soulier,et al.  Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.

[198]  H. Saya,et al.  Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model , 2009, Cancer science.

[199]  Martin J. Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[200]  K. Ozato,et al.  Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. , 2009, Molecular biology of the cell.

[201]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[202]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[203]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[204]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[205]  R. Cole,et al.  Barrier-to-Autointegration Factor Proteome Reveals Chromatin-Regulatory Partners , 2009, PloS one.

[206]  D. Richel,et al.  Tumor microvasculature supports proliferation and expansion of glioma‐propagating cells , 2009, International journal of cancer.

[207]  M. Blasco,et al.  The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.

[208]  D. Gilliland,et al.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.

[209]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[210]  G. Badaracco,et al.  Interaction between the inner nuclear membrane lamin B receptor and the heterochromatic methyl binding protein, MeCP2. , 2009, Experimental cell research.

[211]  Dinshaw J. Patel,et al.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger , 2009, Nature.

[212]  G. Neri,et al.  Faculty Opinions recommendation of Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. , 2009 .

[213]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[214]  J. Herman,et al.  An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1. , 2008, Gastroenterology.

[215]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[216]  G. Ming,et al.  G9a and Jhdm2a Regulate Embryonic Stem Cell Fusion‐Induced Reprogramming of Adult Neural Stem Cells , 2008, Stem cells.

[217]  T. Hung,et al.  Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor. , 2008, Journal of molecular biology.

[218]  L. Wessels,et al.  Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions , 2008, Nature.

[219]  Harinder Singh,et al.  Initiation of allelic exclusion by stochastic interaction of Tcrb alleles with repressive nuclear compartments , 2008, Nature Immunology.

[220]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[221]  Elizabeth Kerr,et al.  Recruitment to the Nuclear Periphery Can Alter Expression of Genes in Human Cells , 2008, PLoS genetics.

[222]  Scott A. Armstrong,et al.  MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.

[223]  Michael R. Green,et al.  An elaborate pathway required for Ras-mediated epigenetic silencing , 2007, Nature.

[224]  C. Lengner,et al.  Oct4 expression is not required for mouse somatic stem cell self-renewal. , 2007, Cell stem cell.

[225]  G. Natoli,et al.  The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.

[226]  A. Feinberg,et al.  Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. , 2007, Journal of the National Cancer Institute.

[227]  K. Wilson,et al.  An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture. , 2007, Biochemistry.

[228]  G. Wang,et al.  NUP98–NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis , 2007, Nature Cell Biology.

[229]  L. Hou,et al.  Changes in DNA methylation patterns in subjects exposed to low-dose benzene. , 2007, Cancer research.

[230]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[231]  L. Aaltonen,et al.  A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition , 2006, Nature Genetics.

[232]  A. Kaneda,et al.  High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk , 2006, Clinical Cancer Research.

[233]  B. C. Wong,et al.  Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation , 2006, Gut.

[234]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[235]  N. Amariglio,et al.  The nuclear-envelope protein and transcriptional repressor LAP2β interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation , 2005, Journal of Cell Science.

[236]  F. Couch,et al.  CBP truncating mutations in ovarian cancer , 2005, Journal of Medical Genetics.

[237]  G. Blandino,et al.  The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. , 2005, Molecular cell.

[238]  Rudolf Jaenisch,et al.  Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial Tissues , 2005, Cell.

[239]  J. Califano,et al.  Differential DNA Hypermethylation of Critical Genes Mediates the Stage-Specific Tobacco Smoke-Induced Neoplastic Progression of Lung Cancer , 2005, Clinical Cancer Research.

[240]  A. Feinberg,et al.  Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice , 2005, Science.

[241]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[242]  Stephen Lam,et al.  Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers , 2003, International journal of cancer.

[243]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[244]  R Alexandra Goldbohm,et al.  Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. , 2003, Cancer research.

[245]  S. Hirohashi,et al.  Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. , 2003, Cancer letters.

[246]  Andrew P Feinberg,et al.  Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. , 2002, American journal of human genetics.

[247]  P. D. Dal Cin,et al.  BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). , 2001, The American journal of pathology.

[248]  Victor V Lobanenkov,et al.  Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive , 2000, Current Biology.

[249]  A. Hassan,et al.  Insulin-like Growth Factor II Supply Modifies Growth of Intestinal Adenoma in ApcMin/+ Mice , 2000 .

[250]  J. Mason,et al.  Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. , 1999, The Journal of nutrition.

[251]  R. Jirtle,et al.  Genomic imprinting: implications for human disease. , 1999, The American journal of pathology.

[252]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[253]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[254]  A. Feinberg,et al.  Loss of imprinting in hepatoblastoma. , 1995, Cancer research.

[255]  S. Zhan,et al.  Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. , 1994, The Journal of clinical investigation.

[256]  J. Rowley,et al.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.

[257]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.

[258]  A. Feinberg,et al.  Relaxation of imprinted genes in human cancer , 1993, Nature.

[259]  M. Eccles,et al.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour , 1993, Nature.

[260]  L. Poirier,et al.  c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. , 1988, Carcinogenesis.

[261]  E. Farber,et al.  The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. , 1984, Carcinogenesis.

[262]  L. Poirier,et al.  Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. , 1984, The Biochemical journal.

[263]  A. Ferrando,et al.  PHF6 mutations in adult acute myeloid leukemia , 2011, Leukemia.

[264]  E. Greer,et al.  Members of the H 3 K 4 trimethylation complex regulate lifespan in a germline-dependent manner in C . elegans , 2010 .

[265]  B. Christensen,et al.  Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. , 2009, Cancer research.

[266]  S. Sharkis,et al.  hematopoietic stem cells that may reside in the low-oxygenic niche A low level of reactive oxygen species selects for primitive , 2007 .

[267]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[268]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[269]  J. Trosko,et al.  Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells. , 2006, Contributions to microbiology.

[270]  A. Feinberg,et al.  Epigenetic variability and the evolution of human cancer. , 2003, Advances in cancer research.

[271]  D. Levy,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[272]  A. Hassan,et al.  Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. , 2000, Cancer research.

[273]  J. Biegel,et al.  Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. , 1999, Cancer research.